RNA interference-directed silencing of VPAC1 receptor inhibits VIP effects on both EGFR and HER2 transactivation and VEGF secretion in human breast cancer cells

Ana Valdehíta(Universidad de Alcalá), Juan Carlos Prieto(Universidad de Santiago de Chile), Ana M. Bajo(Universidad de Alcalá), Marı́a J. Carmena(Universidad de Alcalá)
Molecular and Cellular Endocrinology
August 29, 2011
Cited by 30


Related Papers